Linking fatherhood to prostate cancer risk

Future Oncology

Volumn 4, Issue 2, 2008, Pages 137-140

  Jørgensen, Kristian T ^a   Frisch, Morten ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANOLONE; TESTOSTERONE;

AGING; ANDROGEN BLOOD LEVEL; CANCER RISK; CARCINOGENESIS; CHILDLESSNESS; EDITORIAL; FATHER; HEALTH BEHAVIOR; HUMAN; MALE INFERTILITY; PRIORITY JOURNAL; PROGENY; PROSTATE CANCER; RACE DIFFERENCE; RISK REDUCTION; SEMINAL PLASMA; SPERMATOGENESIS; TESTOSTERONE BLOOD LEVEL; TRINUCLEOTIDE REPEAT; Y CHROMOSOME; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSTATE TUMOR; RISK FACTOR; SEX DIFFERENCE;

ANDROGENS; FATHERS; HUMANS; INFERTILITY, MALE; MALE; PROSTATIC NEOPLASMS; RISK FACTORS; SEX FACTORS;

EID: 43049134881     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/14796694.4.2.137     Document Type: Editorial

References (25)

1. Gronberg H: Prostate cancer epidemiology. Lancet 361(9360), 859-864 (2003).
2. Platz EA, Giovannucci E: Prostate cancer. In: Cancer Epidemiology and Prevention. Schottenfeld D, Fraumeni JF Jr (Eds), Oxford University Press, Oxford, UK, 1128-1150 (2006).
3. Giwercman A, Richiardi L, Kaijser M, Ekbom A, Akre O: Reduced risk of prostate cancer in men who are childless as compared to those who have fathered a child: a population based case-control study. Int. J. Cancer 115(6), 994-997 (2005).
4. Harlap S, Paltiel O, Friedlander Y et al.: Prostate cancer in fathers with fewer male offspring: the Jerusalem Perinatal Study cohort. J Natl Cancer Inst. 99(1), 77-81 (2007).
5. Jørgensen KT, Pedersen BV, Johansen C, Frisch M: Fatherhood status and prostate cancer risk. Cancer 112(4), 919-923 (2008).
6. Dennis LK, Dawson DV: Meta-analysis of measures of sexual activity and prostate cancer. Epidemiology 13(1), 72-79 (2002).
7. Negri E, Talamini R, Bosetti C, Montelia M, Franceschi S, La Vecchia C: Risk of prostate cancer in men who am childless. Int. J. Cancer 118(3), 786-787 (2006).
8. Bernstein L, Henderson BE: Exogenous hormones. In: Cancer Epidemiology and Prevention. Schottenfeld D. Fraumeni JF Jr (Eds), Oxford University Press, Oxford, UK, 462-488 (1996).
9. Kaaks R, Lukanova A, Sommersberg B: Plasma androgens, IGF-1, body size, and prostate cancer risk: a synthetic review. Prostate Cancer Prostatic Dis. 3(3), 157-172 (2000).
10. Soronen F, Laiti M, Torn S et al.: Sex steroid hormone metabolism and prostate cancer. J. Steroid Biochem. Mol. Biol. 92(4), 281-286 (2004).
11. Gann PH, Hennekens CH, Ma J, Longcope C, Stampfer MJ: Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst. 88(16), 1118-1126 (1996).
12. Dohle GR, Smit M, Weber RF: Androgens and male fertility. World J. Urol. 21(5), 341-345 (2003).
13. Luboshitzky R, Kaplan-Zverling M, Shen-Orr Z, Nave R, Herer P: Seminal plasma androgen/oestrogen balance in infertile men. Int. J. Androl. 25(6), 345-351 (2002).
14. Meeker JD, Godfrey-Bailey L, Hauser R: Relationships between serum hormone levels and semen quality among men from an infertility clinic. J. Androl. 28(3), 397-406 (2007).
15. Pavlovich CP, King P, Goldstein M, Schlegel PN: Evidence of a treatable endocrinopathy in infertile men. J. Urol. 165(3), 837-841 (2001).
16. Morgentaler A: Testosterone and prostate cancer: an historical perspective on a modern myth. Eur. Urol. 50(5), 935-939 (2006).
17. Carpenter WR, Robinson WR, Godley PA: Getting over testosterone: postulating a fresh start for etiologic studies of prostate cancer. J. Natl Cancer Inst. 100(3), 158-159 (2008).
18. Roddam AW, Allen NE, Appleby P, Key TJ: Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies. J Natl Cancer Inst. 100(3), 170-183 (2008).
19. Schiffer E: Biornarkers for prostate cancer. World J. Urol. 25(6), 557-562 (2001).
20. Ingles SA, Ross RK, Yu MC et al.: Association of prostate canter risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst. 89(2), 166-170 (1997).
21. Dowsing AT, Yong EL, Clark M, McLachlan RI, de Kretser DM, Trounson AO: Linkage between male infertility and trinucleotide repeat expansion in the androgen-receptor gene. Lancet 354(9179), 640-643 (1999).
22. Summers K, Crespi B: The androgen receptor and prostate cancer: a role for sexual selection and sexual conflict? Med. Hypotheses 70(2), 435-443 (2008).
23. Frisch M, Pedersen BV, Wohlfahrt J, Hjalgrim H, Biggar RJ: Reproductive patterns and non-Hodgkin lymphoma risk in Danish women and men. Eur. J. Epidemiol. 21(9), 673-679 (2006).
24. Richiardi L, Akre O, Montgomery SM, Lambe M, Kvist U, Ekbom A: Fecundity and twinning rates as measures of fertility before diagnosis of germ-cell testicular cancer. J. Natl Cancer Inst. 96(2), 145-147 (2004).
25. Bermejo JL, Sundquist J, Hemminki K: Re: prostate cancer in fathers with fewer male offspring: the Jerusalem perinatal study cohort. J. Natl Cancer Inst. 99(11), 901-902 (2007).